e{"id":20261,"date":"2022-07-07T10:20:49","date_gmt":"2022-07-07T10:20:49","guid":{"rendered":"https:\/\/lokerjobsid123.com\/?p=20261"},"modified":"2022-07-07T10:20:49","modified_gmt":"2022-07-07T10:20:49","slug":"choosing-whistleblower-lawyers-for-pharmaceutical-fraud-cases","status":"publish","type":"post","link":"https:\/\/lokerjobsid123.com\/choosing-whistleblower-lawyers-for-pharmaceutical-fraud-cases\/","title":{"rendered":"Choosing Whistleblower Lawyers for Pharmaceutical Fraud Cases"},"content":{"rendered":"
As recent federal hospice scam enforcement actions have demonstrated, how many healthcare businesses and people who’re ready to try to defraud the Medicare and Medicaid hospice advantages applications is on the rise.<\/p>\n
A recently available exemplory case of hospice scam involving a South Carolina hospice is Southern Treatment, Inc., a hospice company that in 2009 compensated $24.7 million to be in an FCA case. The defendant run hospices in 14 different states, also, including Alabama, Georgia, Indiana, Iowa, Kansas, Louisiana, Michigan, Mississippi, Missouri, Ohio, Pennsylvania, Texas, Virginia and Wisconsin. The alleged frauds were that individuals were not entitled to hospice, to humor, weren’t terminally sick, not enough documentation of terminal diseases, and that the business marketed to potential people with the offer of free medicines, products, and the provision of home wellness aides. Southern Treatment also entered in to a 5-year Corporate Integrity Deal with the OIG as part of the settlement. The qui tam relators acquired almost $5 million.<\/p>\n